NeuroScientific Biopharmaceuticals has dosed a fourth Crohn’s disease patient with its StemSmart stem-cell therapy, in a step towards phase two...
Vous n'êtes pas connecté
Maroc - DRUGS.COM - Daily MedNews - 05/Mar 11:15
WEDNESDAY, March 5, 2025 -- Sight-robbing injuries to the cornea can be repaired using a groundbreaking experimental stem cell treatment, a new study shows.The cornea -- the clear outermost layer of the eye -- can become irreversibly damaged if...
NeuroScientific Biopharmaceuticals has dosed a fourth Crohn’s disease patient with its StemSmart stem-cell therapy, in a step towards phase two...
NeuroScientific Biopharmaceuticals dosed a fourth Crohn’s patient with its StemSmart therapy ahead of phase 2 trials for its novel treatment of the...
NeuroScientific Biopharmaceuticals dosed a fourth Crohn’s patient with its StemSmart therapy ahead of phase 2 trials for its novel treatment of the...
NeuroScientific Biopharmaceuticals dosed a fourth Crohn’s patient with its StemSmart therapy ahead of phase 2 trials for its novel treatment of the...
NeuroScientific Biopharmaceuticals dosed a fourth Crohn’s patient with its StemSmart therapy ahead of phase 2 trials for its novel treatment of the...
Findings may lead to new treatment for ‘lazy eye’...
Findings may lead to new treatment for ‘lazy eye’...
MONDAY, Nov. 10, 2025 — A Mayo Clinic team has developed a new way to repair damaged hearts without open-heart surgery, and early results...
MONDAY, Nov. 10, 2025 — A Mayo Clinic team has developed a new way to repair damaged hearts without open-heart surgery, and early results...
In clinical medicine, five core missions have been identified: cell therapy (stem cells, immune cells), cell-based products for chronic and...